Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New study finds racial disparities among elderly Americans in hospital readmissions

Elderly black patients were more likely to be readmitted to the hospital after a prior hospital stay for a heart attack, heart failure, or pneumonia, according to a new study from Harvard School of Public Health researchers.

16 Feb 2011

Racial disparities in readmissions related to both patient race and site of care

Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.

16 Feb 2011

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Two contracts for advanced development of drugs to treat skin and lung injuries associated with acute radiation syndrome (ARS) were awarded this week by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). These contracts are the first by BARDA to address the skin and lung injuries that arise from acute exposure to high levels of ionizing radiation - the type of radiation that results from a nuclear blast.

16 Feb 2011

Over 20% of young children with respiratory viral infections will develop middle ear infections

More than 20 percent of young children with colds or other respiratory viral infections will develop middle ear infections of varying severity—including some mild infections that don't require antibiotics, according to a study in the February issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Feb 2011

Scott & White Healthcare offers TIF procedure to patients with chronic heartburn

Millions of Americans, or 10 percent of the population, suffers from daily heartburn or other symptoms of reflux such as regurgitation, chronic cough, hoarseness and dental erosions. Until recently, many of these patients faced either a lifetime of daily medications, incomplete resolution, or worsening of their symptoms while treatment options were often limited to surgery.

16 Feb 2011

Majority of parents continue to give OTC cough and cold medicines to children under 2

Research has linked over-the-counter cough and cold products to poisoning or death in hundreds of children, ages 2 and younger. Studies have also shown that these medicines do little to control symptoms. As a result, in 2008, the United States Food and Drug Administration formally recommended that OTC cough and cold products not be given to children under age 2.

16 Feb 2011

GAVI chair calls for greater reductions in vaccine prices for developing countries

On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).

16 Feb 2011

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.

16 Feb 2011

New study confirms effectiveness of inhaled epinephrine to treat croup

For more than 30 years, pediatricians have treated children who have croup with inhaled epinephrine to relieve their symptoms quickly. Now, a new review confirms the value of this approach to treat this common respiratory illness, which sometimes turns serious and - in rare instances - can prove fatal.

16 Feb 2011

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Aeolus Pharmaceuticals, a biopharmaceutical company developing a new class of broad spectrum catalytic antioxidant compounds that reduce oxidative stress, inflammation, and subsequent tissue damage-signaling cascades resulting from radiation exposure, today announced that the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, has awarded Aeolus a contract for the advanced development of AEOL 10150 as a medical countermeasure against the pulmonary sub-syndrome of acute radiation syndrome.

16 Feb 2011

Orthofix 2010 net sales increase 3% to $564.4 million

Orthofix International N.V. today announced its results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

ODA offers tips on how to handle winter-related dental injury

Family Day is a chance for parents and kids to enjoy the last few weeks of snowfall, which means tobogganing, skating and snowball fights. But any winter activity comes with a risk of injury to the teeth and mouth. The Ontario Dental Association wants to remind parents to take extra precautions during this holiday and learn what to do in case of a dental injury.

16 Feb 2011

NTI awards $295,172 to BMC chief for acute lung injury study

Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.

15 Feb 2011

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

Baxter International Inc. announced today results of a study published in this week's issue of The Lancet that demonstrate effectiveness and tolerability of Baxter's PREFLUCEL in protecting against seasonal influenza.

From Baxter International Inc. 15 Feb 2011

RPCI offers first FDA-approved cancer treatment vaccine

The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.

15 Feb 2011

Efficacy of zinc in common cold - Review of clinical trials

A new study has added to the existing literature that debates the role of zinc in combating the common cold. It suggests that the supplement might modestly reduce cold duration and severity or maybe even prevent it. The report was published as a Cochrane Review.

15 Feb 2011

Zinc supplements reduce burden of common cold

Zinc supplements reduce the severity and duration of illness caused by the common cold, according to a systematic review published in The Cochrane Library. The findings could help reduce the amount of time lost from work and school due to colds.

15 Feb 2011

FDA requests $4.3 billion to protect and promote health of Americans as part of FY 2012 budget

The U.S. Food and Drug Administration is requesting a budget of $4.3 billion to protect and promote the public health as part of the President's fiscal year 2012 budget — a 33 percent increase over the FDA enacted budget for FY 2010. The FY 2012 request covers the period of Oct. 1, 2011, through Sept. 30, 2012.

15 Feb 2011

Study finds GI bleeding rare outside of ICU, regardless of whether or not patients receive medication

Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.

15 Feb 2011

February is again peak time for influenza across the nation

If you thought the regular seasonal flu has been late making its annual appearance, you might be surprised to learn that based on recent history, it's right on time.

15 Feb 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New study finds racial disparities among elderly Americans in hospital readmissions

Racial disparities in readmissions related to both patient race and site of care

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Over 20% of young children with respiratory viral infections will develop middle ear infections

Scott & White Healthcare offers TIF procedure to patients with chronic heartburn

Majority of parents continue to give OTC cough and cold medicines to children under 2

GAVI chair calls for greater reductions in vaccine prices for developing countries

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

New study confirms effectiveness of inhaled epinephrine to treat croup

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Orthofix 2010 net sales increase 3% to $564.4 million

ODA offers tips on how to handle winter-related dental injury

NTI awards $295,172 to BMC chief for acute lung injury study

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

RPCI offers first FDA-approved cancer treatment vaccine

Efficacy of zinc in common cold - Review of clinical trials

Zinc supplements reduce burden of common cold

FDA requests $4.3 billion to protect and promote health of Americans as part of FY 2012 budget

Study finds GI bleeding rare outside of ICU, regardless of whether or not patients receive medication

February is again peak time for influenza across the nation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in